Pay in 4 interest-free payments of $5.31 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
To our knowledge, this study presents the first real-world efficacy study of any modern GLP-1 use as compared to regular care management in a control group, facilitated by the availability of recent outcomes data up to 2024
Wang H, Listrat A, Meunier B, Gueugneau M, Coudy-Gandilhon C, Combaret L, Taillandier D, Polge C, Attaix D, Lethias C, Lee K, Goh KL, Bechet D
This research was supported by NIH-DK105155, as well as an investigator-initiated research grant from Novo Nordisk
Adequate protein intake is the single most important preventive measure
In very mild AD, the prevalence of apathy is around 14%, rising to 28% in mild AD, 39% in moderate AD, and 61% in severe AD (Starkstein et al., 2006)
US$ 22.08
US$ 25.65
US$ 29.61
